Lapmanee, S.; Bhubhanil, S.; Wongchitrat, P.; Charoenphon, N.; Inchan, A.; Ngernsutivorakul, T.; Dechbumroong, P.; Khongkow, M.; Namdee, K.
Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats. Pharmaceutics 2024, 16, 514.
https://doi.org/10.3390/pharmaceutics16040514
AMA Style
Lapmanee S, Bhubhanil S, Wongchitrat P, Charoenphon N, Inchan A, Ngernsutivorakul T, Dechbumroong P, Khongkow M, Namdee K.
Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats. Pharmaceutics. 2024; 16(4):514.
https://doi.org/10.3390/pharmaceutics16040514
Chicago/Turabian Style
Lapmanee, Sarawut, Sakkarin Bhubhanil, Prapimpun Wongchitrat, Natthawut Charoenphon, Anjaree Inchan, Thitaphat Ngernsutivorakul, Piroonrat Dechbumroong, Mattaka Khongkow, and Katawut Namdee.
2024. "Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats" Pharmaceutics 16, no. 4: 514.
https://doi.org/10.3390/pharmaceutics16040514
APA Style
Lapmanee, S., Bhubhanil, S., Wongchitrat, P., Charoenphon, N., Inchan, A., Ngernsutivorakul, T., Dechbumroong, P., Khongkow, M., & Namdee, K.
(2024). Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats. Pharmaceutics, 16(4), 514.
https://doi.org/10.3390/pharmaceutics16040514
